Introduction
Although not perfect, the mouse provides a very useful model for the study of human cancer. This is particularly so since transgenic technology has allowed us to create very specific mouse models which mimic several aspects of human malignant disease (reviewed in Hutchinson and Muller (2000) ). Among the many transgenic mouse models created since this approach was introduced (Brinster et al., 1984; Stewart et al., 1984) , the Tg.AC mouse (Battalora et al., 2001; Hansen and Tennant, 1994a,b; Hansen et al., 1996; Leder et al., 1990; Spalding et al., 1993) is of special interest and utility. It provides a rapid and sensitive alternative to the two stage initiation/promotion model that requires both mutagens and tumor promoters to produce skin papillomas in mice (Berenblum, 1941; Boutwell, 1964; DiGiovanni, 1992 , DiGiovanni et al., 1993 . This transgene abrogates the need for mutagenic initiators and these mice develop tumors directly in response to wounding or to the application of a tumor promoter. The latter is often an activator of the protein kinase C pathway (such as 12-O-tetradecanoylphorbol-13-acetate (TPA)). Since the occurrence of skin papillomas provides a relatively rapid, reliable and readily assayed response, the Tg.AC mouse has been investigated extensively as a test system for the identification of tumor promoters and carcinogens in toxicologic studies (Dunson et al., 2000; Eastin et al., 1998; Gulezian et al., 2000) .
Despite its importance as a model system, several features of the Tg.AC phenotype have yet to be explained. For example, the Tg.AC mouse bears a multicopy fusion transgene in which the mouse embryonic z-globin promoter drives the expression of the v-Ha-Ras oncogene (Leder et al., 1990) . As expected, this transgene is expressed in fetal hematopoietic tissue and is largely silent in the adult. Nonetheless, skin tumors as well as other malignancies including those of breast, salivary gland, jaw and other tissues arise unexpectedly in this mouse (Cardiff et al., 1993; Hansen et al., 1996) . Three other lines bearing this same transgene do not exhibit the Tg.AC phenotype (A Leder, unpublished) , suggesting that the site and manner of integration influence this phenotypic behavior. In addition, the multicopy transgene locus is quite unstable, occasionally giving rise to TPA-resistant transgenic mice (nonresponders) Thompson et al., 1998 Thompson et al., , 2001 ).
Given that the instability of the Tg.AC locus might contribute to the phenotype, we wished to create a genetic background that aggravated genomic instability. One convenient way of creating an unstable genetic background in vivo is to introduce inactivating mutations in the murine Wrn gene (Lebel and Leder, 1998; Lombard et al., 2000) . Mutations in the human homolog of this gene are responsible for Werner Syndrome, a rare autosomal recessive disorder that causes premature aging and carcinogenesis in affected humans (Epstein et al., 1996; Goto et al., 1996) . Genomic instability is a prominent feature of this disorder and cells from affected individuals display a variety of karyotypic abnormalities (Fukuchi et al., 1990; Maraschio et al., 1986; Melaragno et al., 1995; Scappaticci et al., 1982) . The WRN protein displays DNA helicase, ATPase, and exonuclease activities (Gray et al., 1997; Huang et al., 1998; Kamath-Loeb et al., 1998; Shen et al., 1998; Suzuki et al., 1997) . Further molecular studies have suggested that the WRN protein is required for the efficient operation of either DNA repair, recombination, or replication mechanisms (Brosh and Bohr, 2002; Lebel, 2001 ) and would be an important element in the maintenance of genome stability. Indeed, cells derived from such Wrn mutant mice exhibit an increased spontaneous rate of mutation at the HPRT locus (Lebel and Leder, 1998) corroborating the human findings. Finally, crosses between the Wrn mutant mice and the pink-eyed unstable mice have shown an increased frequency of DNA deletions at the p locus in mice carrying the Wrn mutation (Lebel, 2002) . Thus, the Wrn mutant mice provide us with a genetic tool to examine transgene instability in Tg.AC mice.
In this study, we investigated the structure of the transgene in detail in order to understand the relationship between transgene instability and tumorigenesis in Tg.AC mice. We show that the transgene is inserted into a Line-1 element, a highly repetitive structure that is associated with hypermethylation and gene silencing (Bailey et al., 2000; Bestor, 1998; Lyon, 1998 Lyon, , 2000 Selker, 1999; Yoder et al., 1997) . The resultant structure creates an extended inverted repeat consisting of both transgene and Line-1 sequences. This transgene undergoes recurrent and extensive germ line alterations, some of which affect the tumorigenic phenotype. The occurrence of these mutations is sharply increased in Tg.AC mice deficient in Wrn helicase activity. Our results point to a genetic interaction between the unstable transgene and Wrn and suggest mechanisms, discussed below, that draw together Tg.AC's aberrant expression pattern, its insertion into a potentially silencing Line-1 element and its inherent structural instability.
Results

Characterization of the transgene and its integration site
The tripartite transgene used in creating the Tg.AC mouse is shown diagrammatically in Figure 1a . It consists of the z-globin promoter driving the v-Ha-Ras oncogene, followed by an SV40-polyA addition site. Approximately 20 -40 copies of this transgene have integrated into a single locus on chromosome 11, region A (A Leder unpublished and Humble et al., 2000) . The structure of this locus and its integration site are both complex and difficult to analyse due to the multicopy nature of the transgene. Nonetheless, the structure of this site is likely to be relevant to the aberrant expression of the transgene and its genetic instability. Fortunately, we were able to take advantage of a simplifying deletion that occurred in a Tg.AC mouse and resulted in the loss of all but 1 -3 copies of the transgene (Figure 1b, lane 2) . This mutation does not affect the tumorigenic phenotype and mice carrying this deletion remain responsive to TPA.
Analysis of DNA from the original and from the deletion transgene reveals 7.0 and 3.0 kb EcoRI fragments that could contain fusion overlaps between the transgene and the flanking genomic DNA ( Figure  1b) . Accordingly, we have cloned these two fragments from genomic libraries (as described in Materials and methods) and determined their sequences. These, in turn, allowed us to draw a more detailed map of the locus (Figure 1c,d) . Interestingly, we find that the transgene is embedded within a repetitive DNA element known as a long interspersed nuclear element or Line-1 element (Fanning and Singer, 1987; Ostertag and Kazazian, 2001a; Smit, 1996; Smit et al., 1995) .
Both the right-and the left-hand portion of the integration site contain Line-1 sequences that are in opposite orientation to one another (Figure 1d ). These sequences create inverted repeats consisting of both the transgene and the Line-1 sequence (Figure 1c,d ). While we do not know the full extent of the Line-1 inverted repeat at this site, it is at a minimum 266 bp (nucleotide positions 6125 -6391, based on the Line-1 sequence). Since we have cloned only 570 bp of the Line-1 element at the right-hand portion of the integration site (of which the sequence of the 280 bp EcoRI/BamHI fragment was obtained by inverse PCR, see Figure 1d and Materials and methods), it is quite possible that Line-1 sequences actually extend beyond the right-hand BamHI site shown in Figure 1c ,d. If true, this could considerably extend the size of the inverted repeat. Interestingly, during the integration process, the transgene inserted itself as a head-to-head structure also giving rise to an internal inverted repeat (see palindrome in Figure 1c ). The precise size of the inverted repeat formed by the transgene sequences is also unknown, being dependent upon where among the multiple copies of the Tg.AC construct the headto-head boundary occurs. If it is in the middle (as drawn in the map shown in Figure 1c ) so that number of right-sided repeats (N R ) is equal to the number of left-sided repeats (N L ), then the inverted transgene repeat is quite large. If, however, the number of rightsided repeats is less than one copy (N R =0, Figure 1c) , the inverted repeat is a minimum of 4.4 kb. Regard-less of their exact size, inverted repeats are notoriously unstable structures (Akgun et al., 1997; Gordenin and Resnick, 1998; Waldman et al., 1999) .
Since the sequence of the insertion site was originally determined from a deletion mutation, we wished to determine that it reflected the structure of the original insertion site rather than that of a site created by the secondary deletion event. For that purpose we designed primers consisting of Ras and Line-1 oligos for the right integration site and SV40 and Line-1 oligos for the left integration site (see PCR L and PCR R in Figure 1c ,e, and Materials and methods). PCR reactions were run using DNA from the undeleted transgenic strain and this yielded fragments of the expected length (Figure 1e ). After cloning and sequencing the PCR products (see Materials and methods), we found that the sequence of the undeleted DNA was virtually identical to the sequence of the cloned mutant allele. This indicates that the deletion was internal to the left and right integration boundaries. The sequence at the right integration boundary was:
Ras
Line-1 GGGAAAAðGÞTCTðCÞAAðAÞGðGÞ k TATGGGCACAGGGGAAAAA;
and the sequence at the left integration boundary was:
Bases in parentheses are differences between the genomic sequences we determined and the sequence of the transgene construct. (L1Md-A2; the Accession #M13002 sequence was used for the Line-1 sequence comparison). The four added bases in the RAS sequence and the single added base in the SV40polyA sequence are not sequencing errors, having been determined twice each. Rather, these additions evidently occurred during the transgene integration event. Aside from these additions, all the boundary sequences can be accounted for as portions of the Line-1 element or the transgene. Note that a deletion of the SV40-PA sequence occurred at the right integration boundary, while the transgene is intact at the left boundary. As can be seen in Figure 1d , a Line-1 inverted repeat can be drawn very close to the site of the transgene integration. Since Line-1 inverted repeats are quite common (Ostertag and Kazazian, 2001b) , one can imagine that a large potential hairpin structure (inverted repeat) exists at this site in wild type genomic DNA and that this element might have played a role in targeting the transgene insertion. Unfortunately, we can obtain only limited Line-1 sequence at the righthand integration site ( Figure 1d ) which prevents us from fully appreciating the size of the potential inverted repeat. The 2.9 kb of Line-1 at the left integration boundary begins at Line-1 position 6125 and continues uninterrupted to position 7372, virtually to the 3' end of the Line-1 element. The remaining 1.6 kb consists of scrambled Line-1 sequences, indicating that, like 95% of human Line-1 elements in the genome, this element is also non-functional (Kazazian and Moran, 1998).
The Tg.AC locus undergoes recurrent mutations
In maintaining the Tg.AC mice we and others Thompson et al., 1998 Thompson et al., , 2001 have noted that the locus undergoes recurrent germ line mutations. One, described above, is a large internal deletion that removes most copies of the transgene, but leaves the integration boundaries unaffected (Figure 2 , deletion A). Despite this deletion, mice bearing the rearrangement remain TPA-responsive. Another prevalent mutation is a deletion that covers the right-hand integration site (Figure 2 , deletion B) and removes two BamHI fragments, one of 2.0 kb, entirely within the transgene, and the other, 2.1 kb, extending over the right integration boundary ( Figure 3a , lanes 1 through 4, and Figure 3c , lanes 3 and 4). As originally noted by Honchel et al. (2001) and Thompson et al. (1998 Thompson et al. ( , 2001 , the 2.0 kb BamHI fragment hybridizes to a zglobin promoter probe and includes two head-to-head z-globin promoters (Figure 3a , lanes 5 -8). The 2.1 kb BamHI fragment hybridizes to a v-Ha-RAS probe and consists of 1.4 kb of the v-Ha-Ras and 0.6 kb of the right-hand Line-1 sequences (Figure 2 , deletion B, and Figure 3c , lanes 5 and 6). As noted above, often these two BamHI fragments are deleted together. Occasionally, tumors derived from Tg.AC have suffered a deletion of the 2.0 kb head-to-head z-globin-bearing fragment (or palindrome), leaving the 2.1 BamHI fragment and the PCR fragment at the right-hand integration site unaffected. See, for example, Figure 3b where the PCR analysis shows that four tumors derived from different Tg.AC mice retain their right integration site and their 2.1 kb BamHI fragment (data not shown), while three of the four have lost the more internal 2.0 kb BamHI fragment. Extra bands can also be seen in two of these tumors.
It is worth noting that both the 2.0 and the 2.1 kb BamHI fragments are simultaneously deleted in several of our mutant mice (Figure 3a ,c, lanes 3 and 4). They are likely to represent proximate, if not contiguous, 
in this deletion
The unstable v-Ha-RAS transgene (Tg.AC) interacts with Wrn A Leder et al sequences because, when they are deleted, the transgene copy number is not substantially reduced. If these two fragments are indeed adjacent to one another, that would place the head-to-head z-globin promoter sequence close to the right integration site, resulting in a 4.4 kb inverted repeat (head-to-head, z-promoterRas). It is reasonable to expect that other mutations occur for which we do not have simple and reliable assays, for example, mutations involving the left-hand integration site. Our focus on the right-hand integration site follows from the availability of a highly reliable PCR assay as compared to the less reliable one available for the left-hand integration site. Nevertheless, the data clearly indicate that the Tg.AC locus undergoes recurrent rearrangements in vivo.
Increased transgene instability in a Wrn deficient background
It is reasonable to infer that the unstable nature of the Tg.AC transgene is related to its multicopy tandem and inverted repeat structure. It is further reasonable to infer that this instability is related to its tumorigenic phenotype. If this is true, then conditions that amplify genetic instability should increase the mutation rate at the Tg.AC locus and, in turn, affect tumorigenesis in the Tg.AC mouse. One way of increasing genetic instability in vivo is to introduce a loss-of-function mutation into the Wrn gene. As indicated above, Wrn is the mouse homolog of the human WRN gene, the gene mutated in human Werner Syndrome and associated with genome instability, cancer and premature aging (Epstein et al., 1966; Goto et al., 1996; Maraschio et al., 1986) . Mice with a deletion of a portion of the Wrn helicase domain present an increased mutation rate at specific loci in vitro and in vivo (Lebel, 2002; Lebel and Leder, 1998) . Accordingly, a series of mice were bred that carried the hemizygous transgene and were homozygous mutant at the Wrn locus (Tg.AC/Wrn Dhel/Dhel ). Since the right-hand Tg.AC insertion boundary displayed considerable instability in an otherwise normal genetic background, its deletion was assessed in the Wrn Dhel/Dhel background using the convenient PCR assay described above. As shown in Table 1 , 13 out of 160 Tg.AC/Wrn Dhel/Dhel mice suffered a germ line deletion of the boundary fragment, whereas only two of 220 Tg.AC/Wrn +/+ mice tested experienced the same deletion. In several cases, the structural deletions that occurred on the Tg.AC/Wrn Dhel/Dhel background were examined in more detail by Southern Dhel/Dhel lymph node)). This high incidence of genomic instability in somatic cells is further illustrated by the large variation in the number of transgene copies displayed by cell lines derived from the spleen and lymph nodes of the same Tg.AC/ Wrn Dhel/Dhel mouse ( Figure 4c, lanes 1 -9) . In some cases, the deletions are so extensive that not even a single intact copy of the transgene remains (Figure 4c,  lanes 4, 5, 7, 8) . The transgene locus in cells derived from the spleen of a Tg.AC/Wrn +/+ mouse are quite stable by comparison (Figure 4c, lanes 10 -12) .
Relationship between mutant genotype and TPAresponsiveness
In view of the increase in genotypic instability observed at the Tg.AC locus in the presence of the homozygous Werner mutation, we asked how this could be related to the tumorigenic phenotype. We have noted that susceptibility to TPA-induced papillomagenesis is affected by the genetic background of the Tg.AC mice (A Leder, unpublished) . Since response to TPA treatment is readily assayed, we bred several groups of mice so as to differ from one another in genetic background and in the presence or absence of a functional Wrn gene. The per cent of mice that developed TPA-induced papillomas in each genetically defined group was a measure of responsiveness. As shown in Figure 5c , Tg.AC mice on a sensitive FVB a Statistical analysis using the standard G-test confirm a very significant difference between the two groups (G=13.4; P (G) 50.0002)
The unstable v-Ha-RAS transgene (Tg.AC) interacts with Wrn A Leder et al genetic background were, as expected, the most responsive with over 90% of the mice developing papillomas as measured 10 weeks after treatment was initiated. Such treated mice also serve as a positive control for the effectiveness of TPA treatment. By contrast, Tg.AC mice on a mixed FVB/129/Black Swiss background were less responsive, only 52% developing papillomas as a reflection of modifying genes in that mixed genetic background. Mice carrying the homozygous Wrn mutation on a similarly mixed FVB/129/ Black Swiss background are even less responsive (24%), a result we suspect is due to the occurrence of inactivating mutations that arise at the Tg.AC locus in this particularly unstable background. Both genetic background and the genomic instability associated with Wrn deficiency influence the kinetics of tumor formation and the intensity of tumor eruption, the latter measured as the number of papillomas per treated area of skin. As shown in Table 2 , Tg.AC hemizygous mice bearing the sensitive FVB background begin to develop papillomas 4 weeks after the onset of TPA treatment and have intense papilloma eruptions. In contrast, Tg.AC mice on the FVB/129/ Black Swiss background begin to respond 2 weeks later Figure 5 Incidence of TPA-treated mice that develop papillomas as a function of genetic background and Wrn activity. Five groups of genetically distinct mice were tested for TPA-responsiveness. Each differed from one another as indicated by the genotype shown beneath each column. FVB refers to the inbred FVB mouse line; FVB/129/BS refers to a mixed genetic background composed of the inbred lines, FVB, 129 and the out-bred Black Swiss. Tg.AC refers to hemizygous Tg.AC mice. Each mouse was treated with 5 mg of TPA in 100 ml of acetone twice weekly for 6 weeks. The number of mice with papillomas was scored, in this case, 10 weeks after the initial treatment. 'N' equals the number of mice treated in each group. '%' is the per cent of mice in each group that developed papillomas. The last two columns represent non-transgenic and non-responder mutant transgenic mice, respectively. No mice in either of these two groups developed any tumors. Statistical analysis using the standard G-test confirms a significant difference between the per cent of mice with papillomas in column 2 as compared to column 3 (G=3.9, P (G) 50.048) and their response is decidedly sparser. Interestingly, however, the small group of Tg.AC/Wrn Dhel/Dhel mice on the FVB/129/Black Swiss background that do develop papillomas, develop them quickly, with an onset at 4 weeks, and quite intensely, the papillomas being virtually confluent in the treatment area. It seems that the Wrn Dhel/Dhel mice throw off two extreme phenotypes, one which is extremely responsive and another which is completely unresponsive. We discuss this paradox below.
As noted above, Tg.AC mice are occasionally found to be unresponsive to TPA-induced tumorigenesis Thompson et al., 1998 Thompson et al., , 2001 ). This sporadic inherited phenotype is often a consequence of mutations in the Tg.AC locus that render it permanently inactive, despite the remaining multiple transgene copies. Unresponsiveness due to genetic background and modifying genes are, by contrast, not linked to the Tg.AC locus (A Leder, unpublished data). The availability of a number of mutations in the Tg.AC locus allowed us to assess structural features of the locus that are associated with the TPA-responsive phenotype. Honchel et al. (2001) and Thompson et al. (1998 Thompson et al. ( , 2001 have suggested that preservation of the 2.0 kb head-to-head z-promoter fragment correlates well with tumorigenesis, while a deletion of this fragment is associated with unresponsiveness. Since genetically unresponsive mice can confound toxicologic studies, we wished to pursue this issue further.
As discussed above, two well-characterized mice that carry deletions of both the 2.0 and the 2.1 kb BamHI fragments were indeed unresponsive to TPA treatment (Figure 3a,c, lanes 3 and 4) . On the other hand, mice that retain the right-hand integration site while deleting the 2.0 kb BamHI fragment, the fragment carrying the head-to-head z-globin promoters, retain the ability to develop papillomas in response to TPA treatment (Figures 3b and 4b) . To extend this correlation between the presence or loss of the right-hand integration site and responsiveness to TPA, we tested 13 hemizygous Tg.AC mice and six of their hemizygous offspring, all of whom had lost the right-hand integration site. Three of these mice were on the FVB genetic background while the rest were on a mixed FVB/129/Black Swiss/Wrn Dhel/Dhel background. All 19 TPA-treated mice failed to develop papillomas and failed to develop sporadic tumors as they grew older ( Figure 5, column 5) . Thus, the deletion mutations were transmitted through the germ line and deletion of the right integration site -not loss of the 2.0 kb BamHI fragment -correlates well with inactivation of the transgene. As a complementary test, we treated three Tg.AC mice that carried large internal deletions that spared the right-and left-hand integration sites (similar to the mutation described in Figure 2a ). All three mice (one on the FVB, the other two, on the FVB/129/Black Swiss/Wrn Dhel/Dhel genetic backgrounds) remained responsive to TPA treatment. Therefore, deletions that remove multiple transgene copies, but spare the insertion boundaries, can leave the Tg.AC locus responsive (Figure 2a) . On the other hand, deletions that remove the right-hand integration site (Figure 2b ) render the locus unresponsive. As a practical matter, the PCR assay we have developed for the right-hand insertion boundary should be useful in detecting many non-responding mice. Our experience, however, indicates that it will not detect all nonresponders. Evidently, there are other mutations not affecting the right-hand integration site that inactivate the TPA-responsive phenotype.
A novel phenotype is manifest in the Tg.AC/Wrn Dhel/Dhel mice: fore-stomach lesions While the major phenotypic feature of the Tg.AC mouse is the development of skin papillomas in response to TPA treatment or wounding, these mice stochastically develop a variety of malignant carcinomas, principally of the jaw (Cardiff et al., 1993; Hansen et al., 1996) . In observing the Tg.AC/Wrn
Dhel/Dhel mice, we noted that some animals, TPA treated or not, would undergo dramatic weight loss between 6 and 8 months of age. When five of these Tg.AC/Wrn Dhel/Dhel mice were autopsied, they were all found to have a carpet of papillomas covering their fore-stomachs and clearly expressing the Tg.AC transgene (Figure 6a,b) . In contrast, only two of six cachectic Tg.AC/Wrn +/+ mice had any papillomas and then only two or three per fore-stomach. Previously, such extensive forestomach papillomas had only been reported in Tg.AC mice gavage-treated with the carcinogen dimethyl vinyl chloride . Such lesions are not seen in Wrn Dhel/Dhel mice that do not carry the Tg.AC transgene. Evidently, the Wrn Dhel/Dhel genetic background can substitute for this genotoxic agent via its role in enhancing genome instability.
Discussion
The Tg.AC mouse carries a transgene that is composed of 20 -40 tandemly repeated copies of the originally injected construct. This repeated structure tends to conceal structural complexities that have doubtlessly resulted from the event that lead to the integration of the transgene. By characterizing a simplified, but nonetheless TPA-responsive deletion mutation of the original transgene, we have been able to offer a more detailed picture of its essential features. First of all, we see that the transgene has integrated into two oppositely oriented Line-1 elements. Such elements consist largely of inactive retrotransposons and are highly repeated in both mouse and human (Kazazian and Moran, 1998) . Further, they are associated with cytosine methylation and, hence, gene silencing. While their physiological function is unknown, Lyon (1998 Lyon ( , 2000 has suggested that they might be involved in condensation of chromatin and inactivation of genes. Being imbedded among Line-1 elements, the Tg.AC transgene is indeed heavily methylated and by and large transcriptionally silent except in fetal hemato-poietic tissue and Tg.AC-induced tumors (A Leder, unpublished; Cannon et al., 1998) .
In addition to the inverted orientation of the Line-1 element repeats, we also see that the transgene copies themselves are oppositely oriented at the right and left integration sites (Figure 1c) . Such repeated sequences, both tandem and inverted, have been associated with genetic instability, indeed they have been called 'at risk motifs' which predispose to mutations (Akgun et al., 1997; Gordenin and Resnick, 1998; Waldman et al., 1999) .
We have characterized several classes of DNA rearrangements that affect the Tg.AC locus. One class results in extensive loss of the tandem repeated copies of the original transgene. If these deletions do not extend into the right-and left-hand integration boundaries, the tumorigenic phenotype is preserved and the locus remains TPA-responsive. Another recurrent class of DNA rearrangements involves loss of the right-hand integration boundary. This mutation results in loss of TPA-responsiveness, whether or not multiple copies of the Tg.AC construct are deleted. This indicates that among the many copies of the transgene only a very few and those located near this boundary are essential for activation of the phenotype. As one would expect, however, an intact right-hand integration boundary does not guarantee TPA-responsiveness.
One of the puzzling features of the Tg.AC mouse is that the transgene is not expressed at detectable levels in normal skin, yet skin-derived papillomas do express the v-Ha-Ras-bearing transgene. These observations have led to the notion that papillomas result from some genetic and/or epigenetic alteration that triggers the aberrant expression of the v-Ha-Rascontaining transgene. Mechanisms that have been considered include methylation (Cannon et al., 1998) and/or mutation involving the transgene or some other collaborating gene. The silent nature of the transgene in the context of the skin could easily follow from the fact that it is driven by the z-globin promoter, a promoter not normally expressed in this tissue. Indeed, other Tg.AC-like mice carrying this construct integrated elsewhere in the genome fail to exhibit the tumorigenic skin phenotype (A Leder, unpublished) indicating that the locus and nature of the integration event are critical. If the Tg.AC transgene is normally silent, as it appears to be, there are two elements of its structure that are associated with gene silencing and could influence its expression through rearrangements; the multicopy tandem and inverted nature of the transgene and the inverted Line-1 elements into which the transgene is inserted. In each case, some alteration of the structure of the transgene might perturb this level of control, allowing the transgene to be activated. Of course, it remains possible that v-Ha-Ras-expressing cells do indeed persist in the skin below our level of detection and, upon TPA treatment, proliferate and form papillomas.
Another question that arises from the behavior of the Tg.AC system is whether the activation of other, non-transgenic oncogenes is required for papilloma formation. Evidence on this point is suggestive, particularly the studies of Owens et al. (1995) who have shown that the carcinogen DMBA increases papillomagenesis in the Tg.AC mice without affecting the structure or expression of the endogenous c-Ha-Ras gene. The genetically unstable nature of the Tg.AC transgene raises the possibility that this very property of instability might be responsible for the initiation of the tumorigenic phenotype. If this is the case, we might expect a more robust tumorigenic phenotype by creating an unstable genetic background in which the Tg.AC transgene and other collaborating oncogenes are subject to a higher incidence of mutation. In doing this, we have noted two seemingly paradoxical consequences of introducing the Tg.AC transgene into the genetically unstable Wrn Dhel/Dhel background. The first involves an eightfold increase in the incidence of TPA-unresponsiveness which correlates with germ line Table 2 , group 2 to group 3). The first aspect of this phenotypic response is almost certainly due to the combined genetic instability inherent in the complex transgene and the generalized genetic instability introduced by the Wrn Dhel/Dhel background. Such mutations obviously occurred in the germ line and inactivated the transgene, giving rise to TPA-unresponsive mice. Given the involvement of the Wrn protein in many aspects of DNA metabolism (Brosh and Bohr, 2002; Lebel, 2001) , the increased papillomagenesis of those Tg.AC/Wrn Dhel/Dhel mice that remain responsive (Table 2) is most likely to occur by way of creating and propagating new somatic mutations in skin epithelial cells.
As noted above, we cannot say whether such postulated new mutations would involve the transgene, some other collaborating gene or both. Our observations with respect to the occurrence of papillomas in the fore-stomach of Tg.AC/Wrn Dhel/Dhel mice offers a clue, however, as to whether genetic mechanisms are involved in Tg.AC papillomagenesis. Cannon et al. (2000) have shown that fore-stomach papillomas can be induced by treating Tg.AC mice with dimethylvinylchloride (DMVC) gavage. DMVC is a mutagen in mammalian cells, though it might also act indirectly as a genotoxic agent. Our results indicate that the Wrn Dhel/Dhel mutation can abrogate the requirement for DMVD in this system, suggesting that it, too, is behaving as a mutagen. Accumulating evidence indicates that the Wrn gene product is involved in resolving aberrant DNA structures that may arise during the process of DNA replication and/or transcription. Such processes generate regions of single-stranded DNA which may inadvertently provide a substrate for the initiation of recombination and potentially illegitimate recombination, thereby increasing the incidence of mutation. While this argument does not allow us to say whether the silent transgene or some other collaborating gene is the target of either the genetic or the chemical mutagen, it does point to genetic rather than epigenetic mechanisms as being required at the initiation stage of tumorigenesis of the Tg.AC mouse. We have also seen that the Tg.AC transgene can undergo inactivating mutations in the germ line ( Figure 5 , column 5). It might, of course, also undergo activating mutations that would fit well with the increased incidence of papillomas in the sensitive Tg.AC/Wrn Dhel/Dhel mice (Table 2) . While most papillomas examined by Southern blot seem to retain their overall transgenic components, it is clear that extensive rearrangements of the transgene have occurred in tumors (Figure 3b ). Although the complexity, repetitious nature and size of the Tg.AC transgene proscribe definitive sequencing comparisons between papillomas and germ line constructs at this point, it may be that the simplifying, but active, germ line deletion mutation we described above (Figure 2a ) will eventually allow us to address this question directly.
Materials and methods
Animals
Tg.AC transgenic mice were created and maintained in our laboratory on the FVB-N genetic background (Leder et al., 1990) . These mice carry multiple copies of the tripartite Tg.AC transgene composed of the z-globin promoter, the vHa-RAS oncogene and a SV40polyA site, all integrated at the Tg.AC locus. All 'transgenic' mice in this study were hemizygous for the transgene. Wrn Dhel/Dhel mutant mice (Werner deficient), lacking part of the Werner helicase domain, were created by homologous recombination in embryonic stem cells (Lebel and Leder, 1998 
Genotyping
DNAs were prepared from biopsied tail-tips as previously described (Leder et al., 1997) . Southern blots for Wrn and dot blots for the transgene were performed as previously described (Leder et al., 1997) . The dot blots were hybridized with an SV40polyA probe and Southern blots, with a HindIII/NotI Wrn fragment that hybridizes to genomic DNA digested with EcoRV.
Identification and cloning of the insertion locus
To clone DNA flanking the transgene insertion site we synthesized two genomic libraries from liver DNA of a Tg.AC mouse that had suffered a large, simplifying deletion at the Tg.AC locus. Liver DNA was digested with EcoRI and run on a 1% agarose gel. Previous Southern blots indicated that 3 and 7 kb fragments were likely to contain the integration sites. Bands from around the 3 and 7 kb were cut from the gel and eluted and a small portion was run again on a 1% agarose gel, blotted and hybridized to verify the presence of the transgene. The remainder of the 3 and 7 kb eluted DNAs were ligated to EcoRI arms of l zap and the genomic libraries were prepared with Gigapack II Gold Packaging Extract (Stratagene).
Cloning the locus provided information regarding specific primers that bridge the transgene and the flanking DNA. The PCR reaction contained 1 ml of diluted or undiluted genomic Tg.AC DNA, 0.2 mM dNTPs, PCR buffer (Boehringer), 0.5 ml of forward (F) primer and 0.5 ml of reverse (R) primer (0.5 mg/ml), 0.5 ml of Taq polymerase in a total reaction volume of 50 ml. The thermal cycle conditions were 948C for 1 min, followed by 35 -40 cycles at 948C for 30 s, 508C for 30 s, and extension at 728C for 1 min. The PCR reaction was analysed by gel electrophoresis (3% Nusieve GTG agarose in TBE buffer). The PCR reaction for the right integration site (Figure 1e) , with primers PA-9 and L-1A, yields a 140 bp fragment (Figure 1e ). An alternative PCR reaction most often Recloning the right and left integration sites by PCR To verify that the PCR fragments that bridge the transgene and the flanking genomic DNA are indeed the correct products unaltered by the simplifying deletion, we ran a PCR reaction on Tg.AC undeleted tail-tip DNA using our right and left integration primers. The appropriate bands were eluted and purified using a Qiagen column, then incubated for 10 min at 708C with dNTP's and Taq polymerase to add deoxyadenosine (A) to the 3' ends. They were then ligated to a linearized PCR2.1 Topo vector containing 3' deoxythymidine (T) overhang (Invitrogen kit). The kit provided competent cells for transformation.
Cloning a genomic fragment using inverse PCR 10 mg of tail DNA were digested with BamHI restriction enzyme followed by phenol/chloroform extraction and ethanol precipitation. The extracted DNA was dissolved in a total of 30 ml of water. 5 ml were then used for self-ligation overnight at room temperature in a total volume of 100 ml of 16 ligase buffer and 5 ml of T4 DNA ligase. The ligated reaction was then precipitated and dissolved in 10 ml of water. 3 ml were used for PCR in a 50 ml reaction. For the amplification, we used Expand Long Template kit (Roche). The thermal cycle conditions were: 948C for 2 min, followed by 40 cycles at 948C and 658C for 30 s, and extension at 688C for 2 min. The primers were: Line-1 oligo (L-1EO): 5'-CCTCATGAAACTCCAAGGCTTCTGCAAGGC and Ras oligo (6380): 5'-CGCAGCTTCGG-TACCAAACTGA.
Transgene detection by in situ-hybridization Non-radioactive Dig labeled probes were used to detect and localize transgene expression. Tissues were fixed in freshly prepared 4% paraformaldehyde in PBS overnight at 48C. They were then embedded in paraffin and sectioned at 5 microns. Slides with sections were dewaxed and fixed once again with 4% paraformaldehyde to preserve mRNA. Prehybridization involved incubation with 0.2 N HCl (to denature proteins), an acetylation step (to reduce nonspecific background), and incubation with 20 mg/ml Proteinase K at room temperature for 20 min. We used the Dig RNA labeling kit (Sp6/T7-Roche#1-175-025) to prepare our probes. Linearized plasmid carrying the SV40-PA sequence provided the template for the sense and antisense Dig labeled probes. Hybridization was performed overnight in a humidified box at 70 -728C. Extensive washing followed at 628C (50% formamide, 26 SSC), 558C (50% formamide, 16 SSC), and at room temperature (16 SSC). The mRNA detection involved incubation with a blocking reagent (sheep serum) and the incubation at room temperature with alkaline phosphatase conjugated anti-Dig antibody (dilution 1 : 500) followed by a wash with TBS (50 mM Tris-Cl pH 7.5, 150 mM NaCl). A color reagent (NBT-BCIP (Roche)) was then placed on sections for 1 -3 days. Sections were counterstained with fast-green.
Skin treatment
5 mg of TPA (12-O-tetradecanoylphorbol-13-acetate) dissolved in 100 ml acetone was applied with a micropipette to the shaven lower back of treated mice. Treatments were applied twice a week for 6 weeks. Mice were examined twice per week.
